Market Forecast News: Endoscope Reprocessing Industry to Hit $4.24B by 2030
The report "Endoscope Reprocessing Market by Product (AER, HLD & Test Strip, Detergent & Wipe, Endoscope Drying, Storage, & Transport System, Tracking Solution), Endoscope Type (Flexible, Rigid), End User (Hospital, ASC, Specialty Clinic) - Global Forecast to 2030", is projected to reach USD 4.24 billion by 2030 from USD 2.71 billion in 2025, at a CAGR of 9.4% during the forecast period.
Browse 332 market data Tables and 49 Figures spread through 297 Pages and in-depth TOC on "Endoscope Reprocessing Market - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/endoscope-reprocessing-market-219094994.html
The endoscope reprocessing market is experiencing steady global growth, driven by key factors such as the rising number of endoscopy procedures for diagnosing and treating chronic diseases, the increased risk of endoscope-associated infections, and healthcare authorities' growing focus on strict reprocessing guidelines to ensure patient safety. Additionally, the aging population and the rise in age-related illnesses have increased demand for endoscopic procedures, boosting the need for effective reprocessing solutions. The market is also supported by substantial investments aimed at upgrading healthcare infrastructure, enhancing infection control practices, and advancing research in endoscopy-related fields. With ongoing developments in automated and high-level disinfection technologies, the endoscope reprocessing market is expected to continue growing in the coming years.
By product, the endoscope reprocessing consumables segment is expected to grow at the fastest rate in the endoscope reprocessing market during the forecast period.
By product, the endoscope reprocessing market is segmented into endoscope reprocessing equipment, endoscope reprocessing consumables, and endoscope tracking solutions. During the forecast period, the endoscope reprocessing consumables segment is expected to grow at a faster rate in the endoscope reprocessing market. This is mainly due to the recurring demand for disinfectants, detergents, enzymatic cleaners, test strips, and other consumables required in every cycle of endoscope reprocessing. Moreover, the increasing volume of endoscopic surgeries and diagnostic procedures is fueling the regular consumption of these products. The growing focus on infection prevention, tighter regulatory guidelines for disinfection, and ongoing product advancements in high-level disinfectants and enzymatic formulations are further boosting this segment’s growth.
By end user, hospitals & ambulatory surgery centers held the largest share in the endoscope reprocessing market in 2024.
By end user, the endoscope reprocessing market is segmented into hospitals & ASCs, specialty clinics, and other end users. In 2024, hospitals & ASCs held the largest market share, mainly due to the high volume of endoscopic procedures performed in these settings, the presence of advanced infrastructure for reprocessing, and a greater focus on following infection control guidelines. Additionally, rising hospital admissions related to gastrointestinal, respiratory, and urological disorders—especially among the aging population—are driving higher endoscope usage and increasing the demand for reprocessing products. The availability of skilled personnel dedicated to reprocessing departments and integrated tracking systems also support this segment's dominance.
North America commanded the largest market share in 2024.
The endoscope reprocessing market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America held the largest portion of the global market. This leadership is due to several key factors, including the high number of endoscopic procedures performed each year, especially in the United States and Canada. For example, the U.S. alone conducts over 17.7 million gastrointestinal endoscopies annually, greatly fueling the need for reliable and efficient reprocessing solutions. Additionally, the strong healthcare infrastructure, strict infection control regulations enforced by agencies such as the FDA and CDC, and increased awareness of endoscope-related infection risks have resulted in greater adoption of advanced reprocessing systems in healthcare settings. Furthermore, the presence of major global market players in this region such as Ecolab, CONMED Corporation, Micro-Scientific, LLC (all US-based), ARC Healthcare Solutions (Canada), and Metrex Research, LLC (Canada) has further strengthened North America’s leadership. These companies play a crucial role in driving innovation, launching new products, and supporting large-scale adoption through strategic collaborations and robust distribution networks. The region also benefits from favorable reimbursement policies, rising chronic disease prevalence, and increasing investments in hospital infection control measures, all of which contribute to sustained market growth.
Key Players
Prominent players in the endoscope reprocessing market are ASP (US), Olympus Corporation (Japan), Ecolab (US), STERIS (Ireland), Getinge AB (Sweden), HOYA Corporation (Japan), CONMED Corporation (US), Miele (Germany), Endo-Technik W. Griesat GmbH (UK), and FUJIFILM Holdings Corporation (Japan).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Endoscope Reprocessing Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
